The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women
Abstract
OBJECTIVE: To investigate the prospective association of low-density lipoprotein (LDL) particle diameter with the incidence of fatal and nonfatal coronary artery disease (CAD). DESIGN: A nested case-control study. SETTING: Cases and controls were identified from a population-based sample of men and women combining all of the 5 cross-sectional surveys conducted from 1979 to 1990 of the Stanford Five-City Project (FCP). PARTICIPANTS: Incident CAD cases were identified through FCP surveillance between 1979 and 1992. Controls were matched by sex, 5-year age groups, survey time point, ethnicity, and FCP treatment condition. The sample included 124 matched pairs: 90 pairs of men and 34 pairs of women. MAIN OUTCOME MEASURES: LDL peak particle diameter (LDL size) was determined by gradient gel electrophoresis on plasma samples collected during the cross-sectional surveys (stored at 70 degrees C for 5-15 years). Established CAD risk-factor data were available from FCP baseline measurements. RESULTS: LDL size was smaller among CAD cases than controls (mean +/- SD) (26.17 +/- 1.00 nm vs 26.68 +/- 0.90 nm; P<.001). The association was graded across control quintiles of LDL size. The significant case-control difference in LDL size was independent of levels of high-density lipoprotein cholesterol (HDL-C), non-HDL cholesterol (non-HDL-C), triglyceride, smoking, systolic blood pressure, and body mass index, but was not significant after adjusting for the ratio of total cholesterol (TC) to HDL-C (TC:HDL-C). Among all the physiological risk factors, LDL size was the best differentiator of CAD status in conditional logistic regression. However, when added to the physiological parameters above, the TC:HDL-C ratio was found to be a stronger independent predictor of CAD status. CONCLUSION: LDL size was significantly smaller in CAD cases than in controls in a prospective, population-based study. These findings support other evidence of a role for small, dense LDL particles in the etiology of atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the reduction in ratio of total to HDL cholesterol, which has been identified as a predictor of coronary heart disease (35), was not significantly different between the 2 diets.”
From Effects of Low-Carbohydrate Diets Versus Low-Fat Diets on Metabolic Risk Factors: A Meta-Analysis of Randomized Controlled Clinical Trials (2012) · cites this paper as [35]
Citations
Cites
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.
Schuler, G. C., Hambrecht, R., Schlierf, G., Niebauer, J., Hauer, K. A., Neumann, J., Hoberg, E., Drinkmann, A., Bacher, F., & Grunze, M. F. (1992) · Circulation · doi:10.1161/01.cir.86.1.1 · Cited by 1,339
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122
Identification of multiple subclasses of plasma low density lipoproteins in normal humans.
Krauss, R. M., & Burke, D. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38178-5 · Cited by 992
Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded Definition
Reaven, G. M. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.001005 · Cited by 908
NHLBI funding policies. Enhancing stability, predictability, and cost control.
Lenfant, C. L. (1994) · Circulation · doi:10.1161/01.cir.90.1.1 · Cited by 763
Graaf, J. D., Hak-Lemmers, H. L. M., Hectors, M. P. C., Demacker, P. N. M., Hendriks, J. C. M., & Stalenhoef, A. F. H. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.298 · Cited by 714
Reaven, G. M., Chen, Y. I., Jeppesen, J., Maheux, P., & Krauss, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116541 · Cited by 687
Chait, A., Brazg, R., Tribble, D. L., & Krauss, R. M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90144-e · Cited by 554
Cited by
Sorted by citations
Items 601–700 of 847
Maki, K. C., Davidson, M. H., Marx, P., Cyrowski, M. S., & Maki, A. C. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00771-7 · Cited by 11
Ratio of Dense to Buoyant LDL Subclass is Associated with LDL Density Phenotype (VLDL-5)
Ahmed, H. M. (2013) · The Open Chemical and Biomedical Methods Journal · doi:10.2174/1875038901306010001 · Cited by 10
A Descriptive Study of Atherogenic Indices in Patients Admitted to a Tertiary Care Hospital
Dharmaraj, S., Rajaragupathy, S., & Denishya, S. (2022) · Cureus · doi:10.7759/cureus.32231 · Cited by 10
“The potential value of non-HDL-C levels as a predictor of cardiovascular mortality has been proven in the literature [16].”
BackgroundDivers, J., Sale, M., Lu, L.-Y., Chen, W.-M., Lok, K. H., Spruill, I. J., Fernandes, J., Langefeld, C. D., & Garvey, W. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m001842 · Cited by 11
Plasma lipids in patients with inflammatory bowel disease
Kul, Ş., Çalışkan, Z., Güvenç, T. S., Güvenç, R. Ç., & Çalışkan, M. (2020) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01649-2 · Cited by 10
Clifton, P. M., Noakes, M., & Nestel, P. J. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32167-2 · Cited by 10
Manocha, A., Gupta, F., Jain, R., Bhargava, S., Kankra, M., Das, S., & Srivastava, L. M. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1927-9 · Cited by 10
Lilley, S. H., Spivey, J. M., Vadlamudi, S., Otvos, J. D., Cummings, D. M., & Barakat, H. A. (1998) · The Journal of Clinical Pharmacology · doi:10.1177/009127009803801204 · Cited by 10
Mo, C.-Y., Pu, J., Zheng, Y., & Li, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02235-5 · Cited by 9
“Elevated levels of small, dense LDL are strongly associated with the risk of coronary artery disease [60–62], whereas large HDL appears to be protective [63, 64].”
BackgroundWilke, R. A. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.86 · Cited by 9
Yang, Q., Zou, Y., Lang, Y., Yang, J., Wu, Y., Xiao, X., Qin, C., Zhao, Y., & Liu, F. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2369701 · Cited by 10
Trajkovska, K. T., Labudović, D. D., Jovanova, S., Jaglikovski, B., & Alabakovska, S. B. (2011) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2011.2569 · Cited by 9
Wu, B., Yu, Z., Tong, T., Tong, X., Yang, Y., Tang, Y., Ren, H., Liao, Y., & Liao, J. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23085 · Cited by 9
Connelly, M. A., Rivera, J. V., Guyton, J. R., Siddiqui, M. S., & Sanyal, A. J. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15935 · Cited by 9
Yazdandoust, S., Parizadeh, S. M. R., Moohebati, M., Yaghmaei, P., Rahsepar, A. A., Tavallaie, S., Soukhtanloo, M., Khojasteh, R., Paydar, R., Fazlinezhad, A., et al. (2012) · Lipids · doi:10.1007/s11745-012-3706-x · Cited by 9
“Previous reports indicate that there is a linear correlation between the sd-LDL concentrations and the risk of development of cardiovascular events [4, 5].”
BackgroundHigh triglyceride level is associated with severe coronary artery disease in hypertensive subjects
Chen, C., Hwu, C., Lin, M., Tsai, C.-H., & Yeh, H. (2008) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430701840325 · Cited by 9
“Increased levels of small dense LDL have been identified as a risk factor for increased incidence of CAD in several epidemiologic studies (17,18).”
BackgroundYoon, Y., Song, J., Park, H., Park, K. U., & Kim, J. Q. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.076 · Cited by 9
“The association between small dense LDL and CHD was first postulated in a number of retrospective studies (6–9) and was later supported by prospective studies (22, 23).”
BackgroundEffects of diet on genetic regulation of lipoprotein metabolism in baboons
Rainwater, D. L., VandeBerg, J. L., & Mahaney, M. C. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.08.079 · Cited by 9
Small, dense low-density lipoprotein subclass pattern B: Issues for the clinician
Superko, H. R. (1999) · Current Atherosclerosis Reports · doi:10.1007/s11883-999-0050-6 · Cited by 9
Recent developments in the treatment of hypertriglyceridemia
Duriez, P., & Fruchart, J. (1999) · Current Atherosclerosis Reports · doi:10.1007/s11883-999-0047-1 · Cited by 9
“This conclusion is based on the observation that serum triglycerides greater than 1.5 mmol/L (130 mg/dL) are associated with the presence of a LDL subfraction that is small and dense [16] and associated with CAD in some case-control studies [ 17 ].”
BackgroundInfluentialDyslipidaemia in patients with malignant-phase hypertension
Edmunds, E. (2001) · QJM · doi:10.1093/qjmed/94.6.327 · Cited by 9
Insulin Treatment in Type 2 Diabetes
Ryysy, L. (2001) · Työväentutkimus Vuosikirja · Cited by 9
The current state of heart disease
Olivieri, C. (2019) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000197 · Cited by 8
“©2019 Un and particle number are a more accurate assessment of how dangerous LDLs may be.(30,31) Using blood tests like lipoprotein(a) and apolipoprotein B can determine if LDLs in the blood are oxidizing and, subsequently, more atherogenic.”
BackgroundKimura, H., MIYAZAKI, R., Imura, T., Masunaga, S., Shimada, A., Mikami, D., Kasuno, K., Takahashi, N., Hirano, T., & Yoshida, H. (2011) · Nephrology · doi:10.1111/j.1440-1797.2011.01454.x · Cited by 8
“A smaller LDL size was also associated with the incidence and progression of CAD in prospective studies.(11,13,30) Considering that in these studies a reduction in LDL size of several Å was associated with CAD status, a smaller LDL size may be a good surrogate marker of pro-atherogenic lipid profiles even in uraemic p…”
BackgroundAziz, K. M. A. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 9
Hunt, K. J., Kistner‐Griffin, E., Spruill, I. J., Teklehaimanot, A. A., Garvey, W. T., Sale, M. M., & Fernandes, J. K. (2014) · Southern Medical Journal · doi:10.14423/smj.0000000000000172 · Cited by 8
Low density lipoprotein subclass distribution in children with diabetes mellitus
Alabakovska, S. B., Labudović, D. D., Tosheska, K., Spiroski, M. Z., & Todorova, B. (2008) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657031 · Cited by 8
Changes in Small Dense Low-Density Lipoprotein Levels Following Acute Coronary Syndrome
Emadzadeh, M. R., Alavi, M.-S., Soukhtanloo, M., Mohammadpour, T., Rahsepar, A. A., Tavallaie, S., Khojasteh, R., Paydar, R., Amini, M., Parizadeh, S. M. R., et al. (2012) · Angiology · doi:10.1177/0003319712441855 · Cited by 8
“In addition, previous studies have reported that there is a linear correlation between the sdLDL concentrations and the risk of development cardiovascular events.(5,6) It has been Table 2.”
BackgroundResultLipoprotein (a): Perspectives from a lipid-referral program
Rubenfire, M., Vodnala, D., Krishnan, S. M., Bard, R. L., Jackson, E. A., Giacherio, D. A., & Brook, R. D. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.06.009 · Cited by 8
“5 [5–73] mg/dL) than in those without CHD (n5392) (median 13 [4–42] mg/dL, Wilcoxon rank sum test P5 .”
BackgroundCho (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000426 · Cited by 8
“Small dense LDL, which is easily oxidized and glycated via interaction with reactive oxygen species and carbohydrate in the blood, are increased with aging and the incidence of diabetes mellitus and coronary artery disease (7).”
Advances in understanding stroke risk in children – a geneticist's view
Stoll, M., Rühle, F., & Nowak‐Göttl, U. (2013) · British Journal of Haematology · doi:10.1111/bjh.12706 · Cited by 8
“Flow chart of results from PubMed search and exclusion criteria. ª 2013 John Wiley & Sons Ltd 637 British Journal of Haematology, 2014, 164, 636–645 Gardner et al, 1996; Lamarche et al, 1998), also need to be considered as risk factors in paediatric AIS.”
BackgroundSittiwicheanwong, R., Ariyapitipun, T., Gulsatitporn, S., Nopponpunth, V., Abeywardena, M. Y., & Dahlan, W. (2007) · PubMed · Cited by 8
Small Dense LDL: New Marker for Cardiovascular Risk Assessment and its Therapeutic Inflection
Khan, M. S. (2012) · Biochemistry & Analytical Biochemistry · doi:10.4172/2161-1009.1000e118 · Cited by 8
“However, the mass of sd-LDL is independently associated with disease risk [19,20], suggesting that these particles are more directly atherogenic than lbLDL.”
BackgroundComparison of apolipoprotein B and plasma lipids as targets for lipid lowering treatment
Vaverková, H., Frohlich, J. J., Jackuliaková, D., & Novotný, D. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.02.012 · Cited by 8
Intake of trans fatty acids and low-density lipoprotein size in a Costa Rican population
Kim, M. K., & Campos, H. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00029-5 · Cited by 9
Mertens, I. L., Lemieux, I., Verrijken, A., Després, J., & Gaal, L. F. V. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.779 · Cited by 8
[The metabolic syndrome: a cluster of vascular risk factors].
Olijhoek, J. K., Martens, F. M. A. C., Banga, J. D., & Visseren, F. L. J. (2005) · PubMed · Cited by 8
Farooq, S., Generoso, G., Benseñor, I. M., Santos, R. D., Jones, S. R., Moraes, E. G., Blaha, M. J., Toth, P. P., Lotufo, P. A., Staniak, H. L., et al. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119171 · Cited by 8
Distribution of low-density lipoprotein particle size in healthy Korean adult males
Son, J. E., Lee, W., Min, W., Chun, S., Lee, Y.-W., & Park, H. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.042 · Cited by 7
Maki, K. C., Davidson, M., Cyrowski, M. S., Maki, A. C., & Marx, P. (2000) · Journal of the American College of Nutrition · doi:10.1080/07315724.2000.10718910 · Cited by 7
Cardiovascular disease prevention
Keevil, J. G., Stein, J. H., & McBride, P. E. (2002) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(02)00012-x · Cited by 7
“Small, dense LDL-C is easily oxidized and very atherogenic [36].”
BackgroundMedina, W. L., Nunes, V. S., Carrilho, A. J. F., Shimabukuru, A. F. M., Lottenberg, A. M., Lottenberg, S. A., McPherson, R., Krauss, R. M., & Quintão, E. C. R. (2000) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(00)00101-1 · Cited by 7
Hayashi, K., Kurushima, H., Kuga, Y., Shingu, T., Tanaka, K., Yasunobu, Y., Nomura, K., Ohtani, H., Hiraga, T., Toyota, Y., et al. (1998) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007781310827 · Cited by 7
Banga, J. D. (1998) · Vascular Surgery · doi:10.1177/153857449803200307 · Cited by 7
Hogue, J., Lamarche, B., Gaudet, D., Tremblay, A. J., Després, J., Gagné, C., & Couture, P. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.027 · Cited by 6
Bhatti, S. M., Dhakam, S. H., & Khan, M. A. (2009) · Pakistan Journal of Medical Sciences · Cited by 6
Nalkıran, H. S., Şahin, S. B., Ayaz, T., Nalkıran, İ., Güzel, A. İ., Eldeş, T., & Yıldız, Y. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0271 · Cited by 6
Metabolic Syndrome and Preeclampsia
Jeyabalan, A., Hubel, C. A., & Roberts, J. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407866-6.00007-9 · Cited by 6
Coronary revascularization in patients with stable coronary disease and diabetes mellitus
Bhat, S. Z., Yatsynovich, Y., & Sharma, U. C. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/14791641211002469 · Cited by 6
The Role of Advanced Lipid Testing in Clinical Practice
Karalis, D. G. (2007) · Preventive Cardiology · doi:10.1111/j.1520-037x.2007.07333.x · Cited by 6
Association of weight gain with coronary artery disease, inflammation and thrombogenicity
Chaudhary, R., Bliden, K. P., Tantry, U. S., Mohammed, N., Mathew, D. P., Gesheff, M. G., Franzese, C. J., & Gurbel, P. A. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1327-y · Cited by 6
Animal protein consumption among rural households in Kwara State, Nigeria
Muhammad-Lawal, A., & Balogun, G. S. (2007) · Cited by 6
Dyslipidemia and pre-eclampsia
Hubel, C. A. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545634.012 · Cited by 6
Plasma Apolipoprotein(b) to LDL Cholesterol Ratio as a Marker of Small, Dense LDL
Griffin, B. A., Furlonger, N., & Iversen, A. (2000) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456320003700416 · Cited by 6
Ferguson, E. E. (2000) · Disease-a-Month · doi:10.1016/s0011-5029(00)90011-7 · Cited by 6
Ryomoto, K., Suzuki, M., Kanazawa, A., Hasegawa, M., Kimura, Y., Yamamura, T., & Harano, Y. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00256-3 · Cited by 6
EFFECTS OF AEROBIC TRAINING AND GENDER ON HDL-C AND LDL-C SUBFRACTIONS IN YUCATAN MINIATURE SWINE
Kist, W., Thomas, T. R., Horner, K. E., & Laughlin, M. H. (1999) · Cited by 6
Low density lipoprotein subclasses in Asian and Caucasian adolescent boys.
Raschke, V., Elmadfa, I., Bermingham, M., & Steinbeck, K. S. (2006) · PubMed · Cited by 6
Tobin, B. W., & Miller, G. D. (2001) · Journal of Nutrition · doi:10.1093/jn/131.2.333s · Cited by 6
Usefulness of low-density lipoprotein particle size measurement in cardiovascular disease prevention
Brook, R. D., Kansal, M. M., Bard, R. L., Eagle, K. A., & Rubenfire, M. (2005) · Clinical Cardiology · doi:10.1002/clc.4960281109 · Cited by 5
Production of polyacrylamide gradient gel for lipoprotein electrophoretic separation
Fonda, M., Semolic, A., Soranzo, M. R., & Cattin, L. (2003) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.07.009 · Cited by 5
Duran, M. J., Kannampuzha‐Francis, J., Nydam, D. V., & Behling‐Kelly, E. L. (2021) · Frontiers in Animal Science · doi:10.3389/fanim.2021.678085 · Cited by 5
“Quantification of these particles is incorporated into diagnostic algorithms for these diseases (Gardner et al., 1996; Vekic et al., 2007).”
BackgroundSmallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men
Williams, P. T., Superko, H. R., Haskell, W. L., Alderman, E. L., Blanche, P. J., Holl, L. G., & Krauss, R. M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000053385.64132.2d · Cited by 5
Bando, Y., 若栗ひとみ, Aoki, K., Kanehara, H., Hisada, A., Okafuji, K., Toya, D., & Tanaka, N. (2015) · Diabetology International · doi:10.1007/s13340-015-0208-0 · Cited by 5
Diabetes and Cardiovascular Disease
Hill‐Briggs, F., Naqibuddin, M., & Golden, S. H. (2022) · Springer eBooks · doi:10.1007/978-0-387-85960-6_58 · Cited by 5
Distribution of low density lipoprotein subclasses in Macedonian children.
Alabakovska, S. B., Labudović, D. D., Tosheska, K., Spiroski, M. Z., & Todorova, B. (2004) · PubMed · Cited by 5
Hirowatari, Y., Kurosawa, H., Yoshida, H., Doumitu, K.-I., & Tada, N. (2002) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00266-x · Cited by 5
Liu, S., Liu, J., Luo, R., Xu, H., Zhang, W., Meng, J., Liang, Y., & Tao, L. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.031 · Cited by 5
LDL-Subfraktionen und koronare Herzerkrankung — Eine Übersicht
Halle, M., Berg, A. ‐., Baumstark, M. W., & Keul, J. (1998) · Zeitschrift für Kardiologie · doi:10.1007/s003920050187 · Cited by 5
Karabina, S., Pappas, H., Miltiadous, G. A., Bairaktari, E. T., Christides, D., Tselepis, A. D., Elisaf, M., & Siamopoulos, K. C. (2003) · Nephron Clinical Practice · doi:10.1159/000074320 · Cited by 5
The role of fibric acid derivatives in the secondary prevention of coronary heart disease
Krakoff, J. A., Vela, B. S., & Brinton, E. A. (2000) · Current Cardiology Reports · doi:10.1007/s11886-000-0060-z · Cited by 5
Assessing the role of oestrogen in the prevention of cardiovascular disease
Nair, G. V., Klein, K. P., & Herrington, D. M. (2001) · Annals of Medicine · doi:10.3109/07853890109002082 · Cited by 5
LDL oxidation and LDL particle size in the development of atherosclerosis
Liu, M. (2002) · Työväentutkimus Vuosikirja · Cited by 5
Lipoprotein Metabolism Abnormalities in Patients with Chronic Renal Insufficiency
Ali, A. A., Sultan, P., El-Napoli, M., & Fahmy, M. (2010) · Journal of Medical Biochemistry · doi:10.2478/v10011-010-0040-9 · Cited by 4
“A change in LDL subfraction profiles associated with the accumu lation of denser particles is associated with an in creased risk of ischemic heart disease in non-renal popu lations and should be added to the list of poten tially atherogenic disturbances of the lipoprotein me ta bolism associated with uremia (31, 32).”
BackgroundRoy, A., Singh, P. K., Saha, S., Das, A., & Naithani, M. (2022) · Journal of Public Health · doi:10.1007/s10389-022-01702-6 · Cited by 4
“Thus, it may be used to predict levels of small, dense LDL, which is linked to coronary artery disease (Gardner et al. 1996).”
BackgroundHarchaoui, A. K. E., van der Steeg, W. A., Stroes, E. S. G., Kuivenhoven, J. A., Otvos, J. D., Wareham, N. J., Hutten, B. A., Jp, J., Khaw, K., & Boekholdt, S. M. (2007) · Cited by 4
Role of Exercise on Inflammation and Chronic Disease
Buresh, R. J., & Berg, K. E. (2014) · Strength and conditioning journal · doi:10.1519/ssc.0000000000000071 · Cited by 4
“多くのアテローム発生を促す傾向があ ることを示唆する研究もある(11)。し かし、Moraらが指摘するように(22)、 いかなる濃度でもLDLの粒径と粒子 数は逆相関の関係にあるため、Otvos”
Small Dense Low-Density Lipoprotein for Risk Prediction of Acute Coronary Syndrome
Singh, A., Puhan, R., Pradhan, A. K., Ali, W., & Sethi, R. (2021) · Cardiology Research · doi:10.14740/cr1254 · Cited by 4
“Hence, this study was conducted to: 1) investigate the association of sd-LDL as a risk factor in ACS patients; 2) correlate the presence of sd-LDL with severity of CAD as determined by coronary angiography; and 3) to correlate the presence of sd-LDL with short-term outcomes.”
BackgroundInfluentialElevated sdLDL level and LDLR rs688 C>T mutation are independent risk factors for ischemic stroke
Chen, Y., Cai, H., Zhang, J., Su, Y., Wu, Y., Lin, Z., & Zhang, Z. (2022) · Medicina Clínica · doi:10.1016/j.medcli.2022.01.016 · Cited by 4
Hypertriglyceridemia and Low High-Density Lipoprotein: Risks for Coronary Artery Disease?
Lamendola, C. A. (2000) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200001000-00009 · Cited by 4
LIPID AND LIPOPROTEIN BIOMARKERS AND THE RISK OF ISCHEMIC STROKE IN POSTMENOPAUSAL WOMEN
Berger, J. S., McGinn, A., Howard, B. V., Kuller, L. H., Mason, J., Otvos, J., Curb, D. J., Eaton, C., Kaplan, R. C., Lynch, J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)60457-3 · Cited by 4
Manipulating the vascular biology of coronary atherosclerosis in diabetes: New opportunities
Orford, J. L., Kinlay, S., Fernandes, J. L., Behrendt, D., Ganz, P., & Selwyn, A. P. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.110970 · Cited by 4
Targeting triglycerides as prognostic indicators and determining lowest values for patient benefit
Sprecher, D. L. (2001) · Current Cardiology Reports · doi:10.1007/s11886-001-0060-7 · Cited by 4
Lipoprotein subclasses—A changing landscape
Tsai, M. Y., & Cao, J. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-008-0006-3 · Cited by 4
Park, J. S., Park, J., Kim, C. S., Cho, M. H., Kim, H. J., Kim, J., Ahn, C. W., Kim, K. R., Soo, B., Lim, S. K., et al. (2006) · Metabolism · doi:10.1016/j.metabol.2006.07.022 · Cited by 4
Excessive Weight Gain and Effects on Lipids With Intensive Therapy of Type 1 Diabetes
Wei, M. (1998) · JAMA · doi:10.1001/jama.280.23.1991 · Cited by 4
Energy Substrate Partitioning and Efficiency in Individuals With Atherogenic Lipoprotein Phenotype
Faghihnia, N., Siri‐Tarino, P. W., Krauss, R. M., & Brooks, G. A. (2011) · Obesity · doi:10.1038/oby.2011.72 · Cited by 4
Rajan, S., Zalpuri, I., Harrington, A., Cimpeanu, C., Song, X., & Fan, X. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000107 · Cited by 4
“The accumulation of smaller, denser LDL particles in the vessel wall is considered to be a key pathophysiological mechanism responsible for the development of atherosclerosis and cardiovascular disease (Coresh and Kwiterovich, 1996; Gardner et al., 1996; Lamarche et al., 1997).”
BackgroundAssociation between Lp(a) and small dense LDL in menopausal women without metabolic syndrome
Gentile, M., Iannuzzo, G., Mattiello, A., Marotta, G., Rubba, F., Iannuzzi, A., Panico, S., & Rubba, P. (2018) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2018.1481599 · Cited by 4
Hirany, S. V., Rainwater, D. L., Devaraj, S., Othman, Y., Jialal, I., & Kutscher, P. (2003) · American Journal of Clinical Pathology · doi:10.1309/h4e6-ktyu-fff2-3hfn · Cited by 4
Perspectives on Vascular Biology and Diabetes
Eckel, R. (2001) · Journal of Investigative Medicine · doi:10.2310/6650.2001.34105 · Cited by 4
Small, dense low-density lipoprotein: Risk or myth?
Le, N. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0064-4 · Cited by 4
Evidence-Based Performance and Outcome Measures for Diabetes Care
Davidson, M. B. (1997) · Disease Management & Health Outcomes · doi:10.2165/00115677-199702030-00002 · Cited by 4
Inclusion of Lipoprotein Subfractions Among Efficacy Parameters
Superko, H. R. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00263-x · Cited by 4
Zeng, Y., Lin, L., Zheng, W., & Chen, G. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332376 · Cited by 3
“Low HDL-C levels fail to effectively clear oxidative byproducts, worsening vascular damage [36,37].”
A Non-Atherogenic and Atherogenic Lipoprotein Profile in Individuals with Dyslipoproteinemia
Oravec, S., Mikl, J., Gruber, K., & Dostal, E. (2012) · InTech eBooks · doi:10.5772/46067 · Cited by 3
“…density lipoproteins (IDL1, IDL2), and especially, by the presence of small dense low-density lipoproteins (sdLDL), which form LDL 3-7 subfractions, and which are strongly atherogenic (Lamarche et al. 1997; Gardner et al. 1996; Rajman et al. 1996; Halle et al. 1998, Austin et al. 1994).”
Gu, C., Wang, N., Ren, P., Wu, X., Pang, B., Zhang, S., Hou, X., Xu, D., Yuan, Y., & Liu, G. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.12.009 · Cited by 4
Lipoprotein particle alterations due to androgen therapy in individuals with dyskeratosis congenita
Thompson, M. B., Muldoon, D. F., de Andrade, K. C., Giri, N., Alter, B. P., Savage, S. A., Shamburek, R. D., & Khincha, P. P. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103760 · Cited by 3
Morbimortalidad por cardiopatía isquémica en el paciente diabético
Esteve, E., & Ricart, W. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71123-8 · Cited by 3
Levels of apolipoproteins as risk factors for coronary artery disease
Ashmaig, M., Ashmeik, K., Ahmed, A. A., Sobki, S. H., & Abdulla, M. (2011) · Jornal Vascular Brasileiro · doi:10.1590/s1677-54492011000400006 · Cited by 3
“The relationship between small, dense LDL and CHD risk has been described in a range of different situations 17-20 , and HDL sub-fractions are among the new emerging CAD risk factors, and in particular HDL 2b has been shown to be linked to cardiovascular risk 21 .”
Background
Metadata
- Authors
- Gardner, C. D.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Gardner, Christopher D.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1996-09-18
- Volume
- 276
- Issue
- 11
- Pages
- 875
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2050758709
- Cited by
- 843
- References
- 53
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 10 · 2022: 10 · 2021: 16 · 2020: 23 · 2019: 14 · 2018: 7 · 2017: 16 · 2016: 10 · 2015: 23 · 2014: 14 · 2013: 33 · 2012: 22
- FWCI
- 37.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01hl018574-26, 5r01hl021906-19)
- National Heart, Lung, and Blood Institute (T32HL007034, HL21906, HL-18574, 5 T32 HL07034)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- small dense LDL, LDL particle size, coronary artery disease, atherosclerosis, cardiovascular risk factors, TC/HDL-C ratio, HDL cholesterol, non-HDL cholesterol, triglycerides, sex differences
- MeSH terms
- Adult, Aged, Coronary Disease, Cross-Sectional Studies, Electrophoresis, Polyacrylamide Gel, Female, Humans, Lipids, Lipoproteins, LDL, Male, Middle Aged, Prospective Studies, Risk Factors, Body Mass Index, Incidence, Linear Models, Logistic Models, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review